Patient impact

Treeway is a patient-founded and patient-inspired company. Therefore, we are sensitive to the patients’ needs in the development of effective treatment.

Treeway. Drug development inspired by patients.

We believe that the best way to develop drugs is by carefully considering the patients’ needs. Treeway was founded by two patients eager to develop the first effective treatment, not for themselves but for all ALS patients. For the same reason, Treeway will further develop therapies for neurodegenerative diseases involving the opinion of patients accross the whole development program.

Socially responsible drug development at Treeway is about keeping the patients in mind at all stages of the process. It is about developing effective treatment where there is a high medical need in a sustainable way. Our expertise and experience allow for efficient collaboration with patient associations, pharma and research to develop drugs cost-effectively. This allows for the opportunity to reinvest in further research in the field of ALS and other neurodegenerative diseases, where most questions are still unanswered.